$EXAS news
The latest EXAS stock news: headlines, filings, AI summaries and sentiment for $EXAS, updated around the clock.
- Veracyte Reports Q3 2026 Revenue Growth Driven by Afirma and Decipher Prostate
- Myriad Genetics Reports Q3 2026 Results and Announces Prenatal Health Divestiture to Labcorp
- Adaptive Biotechnologies Reports Q3 2026 Revenue Growth and Raised Full-Year MRD Guidance
- Abbott Laboratories Announces Third-Quarter Results and Plan to Spin Off Nutrition Segment
- Abbott Laboratories Reports Q3 2026 Growth Driven by Diagnostics and Medical Devices
- Wall Street's Growing Optimism Toward Abbott Laboratories
- Wall Street's Growing Optimism Toward Abbott Laboratories
- Tempus Agrees to Acquire Cancer Test Maker Personalis for $1.5 Billion
- Abbott Laboratories Raises Full-Year Profit Forecast After Strong Q2 Results
- Abbott Raises 2026 Profit Forecast Due to Strong Performance in Diagnostics and Heart Devices
- Abbott Laboratories Stock Rises on Strong Q2 Results and Raised Earnings Outlook
- Abbott Reports Q2 Earnings Beat and Raises Full-Year Profit Guidance
- Abbott Laboratories Q2 Earnings Preview: Analysts Expect Growth Post Exact Sciences Acquisition
- H.C. Wainwright Upgrades Adlai Nortye's Price Target Amid Positive Outlook on Lead Asset
- Fulgent (FLGT) Reports Q1 2026 Earnings with Revenue Declines and Losses
- Abbott Laboratories Faces Stock Decline Due to Guidance Revision and Regulatory Issues
- Abbott Laboratories Reports Earnings Meeting Estimates but Cuts Guidance, Leading to Stock Decline
- Abbott Laboratories Shares Fall Amid Earnings Beat and Exact Sciences Acquisition Impact
- Abbott Laboratories Q1 2026 Earnings Call Summary
- Abbott Laboratories Q1 Earnings Call Highlights
- Abbott Reports Q1 2026 Earnings Results
- Abbott Reports Slight Profit Beat, Adjusts 2026 Forecast Due to Exact Sciences Acquisition